This federal contract award, with the ID SPE2DB20D2002|SPE2DB24FL85S, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,533.05 firm fixed-price delivery order is for the procurement of the medication GEMTESA 75 MG TABLET 90S. The contract has an ultimate completion date of September 10, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of that larger IDC. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 2/27/25, 1:17 PM